What is the global fibromyalgia treatment market in 2026?

The global fibromyalgia treatment market is projected to be valued at US$ 1.9 Bn in 2026.

What drives the global fibromyalgia treatment market?

Rising prevalence of fibromyalgia and increasing patient awareness of treatment options drive demand for therapies.

What is the growth rate for the global fibromyalgia treatment market?

The global fibromyalgia treatment market is poised to witness a CAGR of 5.4% between 2026 and 2033.

What are the key market opportunities in global fibromyalgia treatment market?

Expansion of non-pharmacological therapies and digital health platforms offers significant growth opportunities.

Who are the key players in the global fibromyalgia treatment market?

Pfizer, Eli Lilly and Company, AbbVie, Inc., and Teva Pharmaceutical Industries Ltd are some of the key players in the fibromyalgia treatment market.

Table of Content - Fibromyalgia Treatment Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Executive Summary
1. Global Fibromyalgia Treatment Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors – Relevance and Impact
Value Added Insights
1. Drug Class Adoption Analysis
2. Recent Drug Class Launches
3. Regulatory Landscape
4. Value Chain Analysis
5. Key Deals and Mergers
6. PESTLE Analysis
7. Porter’s Five Force Analysis
Global Fibromyalgia Treatment Market Outlook:
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
3. Global Fibromyalgia Treatment Market Outlook: Drug Class
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2020 – 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
    1. Antidepressants
    2. Anticonvulsants
    3. Analgesics
    4. Muscle Relaxants
  4. Market Attractiveness Analysis: By Drug Class
4. Global Fibromyalgia Treatment Market Outlook: Treatment
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Treatment, 2020 – 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
    1. Medication
    2. Therapy
    3. Others
  4. Market Attractiveness Analysis: Treatment
5. Global Fibromyalgia Treatment Market Outlook: Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2020 – 2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
    1. Hospitals Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  4. Market Attractiveness Analysis: Distribution Channel
Global Fibromyalgia Treatment Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 – 2025
3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 – 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Fibromyalgia Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Class
  3. By Treatment
  4. By Distribution Channel
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
  1. Antidepressants
  2. Anticonvulsants
  3. Analgesics
  4. Muscle Relaxants
5. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
  1. Medication
  2. Therapy
  3. Others
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Europe Fibromyalgia Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Class
  3. By Treatment
  4. By Distribution Channel
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
  1. Antidepressants
  2. Anticonvulsants
  3. Analgesics
  4. Muscle Relaxants
5. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
  1. Medication
  2. Therapy
  3. Others
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
East Asia Fibromyalgia Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Class
  3. By Treatment
  4. By Distribution Channel
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
  1. Antidepressants
  2. Anticonvulsants
  3. Analgesics
  4. Muscle Relaxants
5. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
  1. Medication
  2. Therapy
  3. Others
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
South Asia & Oceania Fibromyalgia Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Class
  3. By Treatment
  4. By Distribution Channel
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
  1. Antidepressants
  2. Anticonvulsants
  3. Analgesics
  4. Muscle Relaxants
5. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
  1. Medication
  2. Therapy
  3. Others
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Latin America Fibromyalgia Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Class
  3. By Treatment
  4. By Distribution Channel
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
  1. Antidepressants
  2. Anticonvulsants
  3. Analgesics
  4. Muscle Relaxants
5. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
  1. Medication
  2. Therapy
  3. Others
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Middle East & Africa Fibromyalgia Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
  1. By Country
  2. By Drug Class
  3. By Treatment
  4. By Distribution Channel
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026 – 2033
  1. Antidepressants
  2. Anticonvulsants
  3. Analgesics
  4. Muscle Relaxants
5. Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2026 – 2033
  1. Medication
  2. Therapy
  3. Others
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026 – 2033
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Competition Landscape
1. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
2. Company Profiles (Details – Overview, Recent Developments)
  1. Pfizer
    1. Overview
    2. Segments and Drug Class & Distribution Channel
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Eli Lilly and Company
  3. AbbVie, Inc.
  4. Teva Pharmaceutical Industries Ltd.
  5. Johnson & Johnson
  6. Sanofi
  7. GSk plc.
  8. Bayer AG
  9. TONIX Pharmaceuticals Holdings Corp
  10. Virios Therapeutics, Inc.
  11. Aptinyx Inc.
  12. FSD Pharma
  13. Others
Appendix
1. 1. Research Methodology
  2. Research Assumptions
  3. Acronyms and Abbreviations

Fibromyalgia Treatment Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Fibromyalgia Treatment Market by Drug Class (Antidepressants, Anticonvulsants, Analgesics, and Muscle Relaxants), by Treatment (Medication, Therapy, and Others) Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Analysis from 2026 to 2033

Quick Links

Our Partners

Secure Payments Through